BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Psychopharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-016-4460-1PMID 27807606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Attention deficit hyperactivity disorder.

  2018cited by this paper
• Treatments and compositions for attention deficit hyperactivity disorder: a patent review

  2016cited by this paper
• The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins

  2015cited by this paper
• Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.

  2014influential reference
• Synaptic regulation of affective behaviors; role of BDNF.

  2014cited by this paper
• Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood

  2014influential reference
• Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naïve Han Chinese sample.

  2014cited by this paper
• Circadian modulation of memory and plasticity gene products in a diurnal species.

  2014cited by this paper
• Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit–hyperactivity disorder (ADHD)

  2014influential reference
• Sex differences in Parkinson’s disease

  2014cited by this paper
• Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine

  2014influential reference
• Effects of prenatal alcohol exposure and attention-deficit/hyperactivity disorder on adaptive functioning.

  2014influential reference
• Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology

  2014influential reference
• Methylphenidate Ameliorates Depressive Comorbidity in ADHD Children without any Modification on Differences in Serum Melatonin Concentration between ADHD Subtypes

  2014cited by this paper
• Innate BDNF expression is associated with ethanol intake in alcohol-preferring AA and alcohol-avoiding ANA rats.

  2014cited by this paper
• YY162 prevents ADHD-like behavioral side effects and cytotoxicity induced by Aroclor1254 via interactive signaling between antioxidant potential, BDNF/TrkB, DAT and NET.

  2014cited by this paper
• The Physiology of BDNF and Its Relationship with ADHD

  2014cited by this paper
• Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder

  2014cited by this paper
• Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.

  2013influential reference
• Further development of a neurobehavioral profile of fetal alcohol spectrum disorders.

  2013cited by this paper
• In Utero Alcohol Exposure, Epigenetic Changes, and Their Consequences

  2013cited by this paper
• Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.

  2013cited by this paper
• Predominance of D2 Receptors in Mediating Dopamine's Effects in Brain Metabolism: Effects of Alcoholism

  2013cited by this paper
• Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

  2013influential reference
• Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder.

  2013cited by this paper
• Obesity in Men With Childhood ADHD: A 33-Year Controlled, Prospective, Follow-up Study

  2013influential reference
• Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD).

  2013cited by this paper
• Pre- and Postnatal Risk Factors for ADHD in a Nonclinical Pediatric Population

  2013cited by this paper
• Body temperature, activity and melatonin profiles in adults with attention‐deficit/hyperactivity disorder and delayed sleep: a case–control study

  2013cited by this paper
• Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?

  2013cited by this paper
• The release of glutamate from cortical neurons regulated by BDNF via the TrkB/Src/PLC‐γ1 pathway

  2013cited by this paper
• Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study.

  2012cited by this paper
• Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus.

  2012cited by this paper
• Different basal concentration and different response of BDNF to prolonged release methylphenidate between ADHD subtypes

  2012cited by this paper
• pigenetic mechanisms regulating learning and long-term memory

  2012cited by this paper
• Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.

  2012cited by this paper
• Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety

  2012cited by this paper
• Neurochemical and Neuropharmacological Aspects of Circadian Disruptions: An Introduction to Asynchronization

  2011cited by this paper
• ADHDgene: a genetic database for attention deficit hyperactivity disorder

  2011cited by this paper
• Epigenetic marking of the BDNF gene by early-life adverse experiences.

  2011cited by this paper
• Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.

  2011influential reference
• Effects of BDNF polymorphisms on brain function and behavior in health and disease.

  2011cited by this paper
• Psychosocial dwarfism: psychopathological aspects and putative neuroendocrine markers.

  2011cited by this paper
• Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication.

  2011cited by this paper
• Determinants of serum brain-derived neurotrophic factor.

  2011cited by this paper
• Maternal smoking during pregnancy is associated with epigenetic modifications of the brain‐derived neurotrophic factor‐6 exon in adolescent offspring

  2010cited by this paper
• The search for biomarkers for attention deficit/hyperactivity disorder.

  2010cited by this paper
• Prenatal Maternal Stress Associated with ADHD and Autistic Traits in early Childhood

  2010cited by this paper
• Opposite Effects of Stimulant and Antipsychotic Drugs on Striatal Fast-Spiking Interneurons

  2010cited by this paper
• [Validation of the attention deficit hyperactivity disorder adult assessment scale (EDAH) in a teenage population].

  2010cited by this paper
• Meta‐analysis of brain‐derived neurotrophic factor p.Val66Met in adult ADHD in four European populations

  2010cited by this paper
• Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice.

  2010cited by this paper
• Validación de la escala de evaluación del trastorno por déficit de atención/hiperactividad (EDAH) en población adolescente

  2010cited by this paper
• Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate.

  2010cited by this paper
• Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men.

  2009influential reference
• Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study

  2009cited by this paper
• Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression

  2009influential reference
• Involvement of brain‐derived neurotrophic factor (BDNF) in the functional elimination of synaptic contacts at polyinnervated neuromuscular synapses during development

  2009cited by this paper
• Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD).

  2008cited by this paper
• Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder

  2008cited by this paper
• Interaction between BDNF and Serotonin: Role in Mood Disorders

  2008influential reference
• A Study of how Socioeconomic Status Moderates the Relationship between SNPs Encompassing BDNF and ADHD Symptom Counts in ADHD Families

  2007cited by this paper
• Neurosteroids in the context of stress: implications for depressive disorders.

  2007influential reference
• Attention-Deficit/Hyperactivity Disorder

  2005cited by this paper
• Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry.

  2005influential reference
• An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences

  2005cited by this paper
• Stimulants and the developing brain.

  2005cited by this paper
• Attention-deficit hyperactivity disorder

  2005cited by this paper
• Enhanced Reactivity and Vulnerability to Cocaine Following Methylphenidate Treatment in Adolescent Rats

  2001cited by this paper
• Neuronal instability: implications for Rett's syndrome.

  2001influential reference
• Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities.

  1999cited by this paper
• The effect of dehydroepiandrosterone (DHEA) on Zucker rat food selection and hypothalamic neurotransmitters.

  1997cited by this paper
• Neurotrophins and Neuronal Plasticity

  1995cited by this paper
• PSYCHOPHARMACOLOGY

  1957cited by this paper

• Kirenol alleviates cerebral ischemic injury by promoting synaptic plasticity via HDAC2-mediated BDNF expression.

  2025cites this paper
• Biomarkers of Depression among Adolescent Girls: BDNF and Epigenetics

  2024cites this paper
• The effects of BDNF rs6265 and FGF21 rs11665896 polymorphisms on alcohol use disorder-related impulsivity in Han Chinese adults

  2024cites this paper
• BDNF, proBDNF and proBDNF/BDNF ratio with electroencephalographic abnormalities in children with attention deficit hyperactivity disorder: Possible relations to cognition and severity

  2024cites this paper
• Assessment of BDNF and sialic acid levels in children with ADHD: Relation of chronotypes

  2024cites this paper
• The Role of BDNF and NPY Levels, Effects of Behavioral Systems and Emotion Regulation on Internet Addiction in Adolescents

  2023cites this paper
• Extracting gait and balance pattern features from skeleton data to diagnose attention deficit/hyperactivity disorder in children

  2023cites this paper
• Brain-derived neurotrophic factor (BDNF) levels in children and adolescents before and after stimulant use a systematic review and metanalysis.

  2023cites this paper
• Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study

  2022cites this paper
• Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment

  2022cites this paper
• Chronic Pain and Psychiatric Conditions

  2022cites this paper
• BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism

  2022cites this paper
• Cord serum brain-derived neurotrophic factor levels at birth associate with temperament outcomes at one year

  2022cites this paper
• Implication of saturated fats in the aetiology of childhood attention deficit/hyperactivity disorder - A narrative review.

  2022cites this paper
• Biomarkers in Child and Adolescent Depression

  2021cites this paper
• ADHD: Reviewing the Causes and Evaluating Solutions

  2021cites this paper
• Plasma brain-derived neurotrophic factor (BDNF) in Egyptian children with attention deficit hyperactivity disorder

  2021cites this paper
• Methylphenidate ameliorates the homeostatic balance between levels of kynurenines in ADHD children.

  2021influential citation
• DNA methylome perturbations: an epigenetic basis for the emergingly heritable neurodevelopmental abnormalities associated with maternal smoking and maternal nicotine exposure

  2021cites this paper
• EEG/ERP-based biomarker/neuroalgorithms in adults with ADHD: Development, reliability, and application in clinical practice

  2020cites this paper
• Brain-Derived Neurotrophic Factor Val66Met induces female-specific changes in impulsive behaviour and alcohol self-administration in mice.

  2020cites this paper
• Bisphenol A and its analogues: A comprehensive review to identify and prioritize effect biomarkers for human biomonitoring.

  2020cites this paper
• Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype/Presentation: Research Progress and Translational Studies

  2020cites this paper
• Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan.

  2020cites this paper
• Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology

  2020cites this paper
• Peripheral Brain-Derived Neurotrophic Factor and Contactin-1 Levels in Patients with Attention-Deficit/Hyperactivity Disorder

  2019cites this paper
• PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics

  2019cites this paper
• [Research advances in pathogenesis of attention deficit hyperactivity disorder].

  2018cites this paper
• Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: A comprehensive systematic review and meta-analysis.

  2018cites this paper